The PennZone

  • Home
  • Business
  • Health
  • Construction
  • Financial
  • Automotive
  • Technology
  • Music
  • Arts

Lineus Medical Receives Innovative Technology Contract from Vizient for SafeBreak® Vascular
The PennZone/10180170

Trending...
  • Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
  • Assent Recognizes Manufacturers for Leading Supply Chain Sustainability Programs
  • Bookmakers Review Releases 2028 Democratic Nominee Betting Odds: Newsom Leads Early Field
Lineus Medical
Contract awarded for products that bring improvement to health care industry

FAYETTEVILLE, Ark. - PennZone -- Lineus Medical announced its SafeBreak® Vascular has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company. The contract was awarded based on the recommendation of SafeBreak Vascular by hospital experts who serve on one of Vizient's member-led councils, and it signifies to Vizient members unique qualities that potentially bring improvement to the health care industry.

Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient's Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.

SafeBreak Vascular is the first of its kind Force-Activated Separation Device (FASD) on the market. SafeBreak is installed in the patient's IV line and separates when a harmful force is placed on an IV line, protecting the IV catheter. When it separates, valves on each side close to prevent the loss of blood and medication. In a large randomized controlled trial, SafeBreak reduced IV complications requiring an IV restart by 44%1. SafeBreak is the first FASD on the market to utilize this innovative approach of intentionally being the weak link in the IV line, giving clinicians the ability to address a long felt problem with a novel solution.

More on The PennZone
  • Global Innovators Take the Stage at the WorldUpstart Accelerator Showcase in Philadelphia
  • HR Soul Consulting Recognized as a 2025 Inc. Power Partner Award Winner for the Fourth Consecutive Year
  • Brazil 021 Chicago Launches New Website and Expands with No-Gi Classes for All Levels
  • American Star Guard Unveils a Powerful Rebrand and Expanded Security Services Throughout Nevada
  • PlaceBased Media Expands Point-of-Care Advertising Inventory Across U.S. Clinic Network

"We're thrilled to receive this Innovative Technology contract offering Vizient members easier access to SafeBreak Vascular and view this as further validation of the way it addresses the persistent problem of IV complications," said Vance Clement, CEO of Lineus Medical. "We believe integrating SafeBreak into clinical practice is a critical step towards Force-Activated Separation Devices becoming the standard of care for IV therapy," said Spencer Jones, Founder and Chief Technology Officer of Lineus Medical.

"Our member councils reviewed and determined SafeBreak Vascular should be recognized with an Innovative Technology contract based on its potential to make an incremental difference in health care," said Kelly Flaharty, director of contract process for Vizient. "Congratulations to Lineus Medical on receiving this contract status."

Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

More on The PennZone
  • Nola Blue Records signs Curtis Salgado
  • Flexible Plan Investments launches FlexDirex, a first-to-market suite of single-stock ETF strategies in the U.S
  • Cody Keller Bookkeeping Empowers Harrisburg Entrepreneurs with Stress-Free Financial Management
  • Revenue Optics Ignites AI Revolution in Industrial Distribution
  • Arnica Unveils "Arnie AI" to Secure the Future of AI-Driven Software Development

###

Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced when a force-activated separation device is used. Learn more
at www.lineusmed.com and follow us on LinkedIn or Twitter.

1. Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2016; 38(3): 189-203.

MKG-0135 Rev. 00

Source: Lineus Medical
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer
  • $73.6 Million Multi-Year Backlog and Florida State Term Contract Drive Momentum for AI-Cybersecurity Pioneer: Cycurion, Inc. (N A S D A Q: CYCU) $CYCU
  • Year-Round Deals for Customers With Square Signs
  • SecurePII Raises US$3.5M (A$5M) to Unlock AI and Compliance for Voice Data and Expands Global Presence
  • Peter Coe Verbica Stands with Rural Families and Horse Owners: "Keep Horses Classified as Livestock"
  • The Mobile-First Company Raises $12M to Build Simple, Powerful Software for Small Teams
  • Lick Pineapple Flavored Massage Oil Outperforming and Enticing
  • Cerberus ODC in Collaboration with NVIDIA Launches All-American AI-RAN Stack, Enabling AI-Native 5G Today and Accelerating the Path to 6G
  • National Compliance Firm issues Artificial Intelligence Policy Program for Mortgage Banking
  • Pastor Darrell Armstrong Suspends Gubernatorial Campaign And Endorses Mikie Sherrill
  • Dr. Johnny Shanks Attends Full Arch Growth Conference 2025
  • Offline Asset Protection: NJTRX Implements 98 Percent Cold Storage as Industry Faces 2 Billion USD Losses
  • Thousands of Smiles, Millions of Logo Views: RoarFun Brings Emotions Into Premium Retail Spaces with Formula Simulator for Immersive Brand Activation
  • Qvarz LLC Expands Global Reach with High-Precision Quartz Cuvettes and Optical Components
  • $300 Million Web3 Initiative and ZIGChain Partnership Power $20 Target in Noble Capital Markets Report for SEGG Media (N A S D A Q: SEGG)
  • Assent Recognizes Manufacturers for Leading Supply Chain Sustainability Programs
  • Arc Longevity Sells Out Debut Women's Creatine Gummy
  • Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
  • Phinge, Home of Netverse, Through its Extensive Software & Hardware Patent Portfolio, Shows Founder & CEO Robert DeMaio's Vision & Innovation
  • OddsTrader Reveals Early Favorites and Best Bets to Win March Madness 2026

Popular on PennZone

  • New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them - 393
  • Rep. Gina H. Curry and Dr. Conan Tu Inspire at Kopp Foundation for Diabetes Hybrid Fundraising Gala and National Leadership Forum - 318
  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks - 279
  • Root Canal Specialist In Frederick Maryland Joins Pearlfection Dentistry
  • Some Music for Donald's Bad Day
  • Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
  • Heritage at South Brunswick Announces New Single-Family Home Collection
  • Cancer Survivor Roslyn Franken Marks 30-Year Milestone with Empowering Gift for Women Survivors
  • Hiclean Tools Releases HCX2100 Electric Pressure Washer
  • Jaipur's Savista Retreat announces $299 all-inclusive nightly rate for two for the 2026 season, including meals and city-center transfers

Similar on PennZone

  • Pioneering the Future of Human-Computer Interaction Through AI-Powered Neural Input Technology: Wearable Devices Ltd. (N A S D A Q: WLDS)
  • PlaceBased Media Expands Point-of-Care Advertising Inventory Across U.S. Clinic Network
  • CCHR Exposes Harms Behind Today's Mental Health Awareness Campaigns
  • Parkchester Oral & Maxillofacial Surgery Celebrates 450+ 5-Star Reviews
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer
  • Dr. Johnny Shanks Attends Full Arch Growth Conference 2025
  • Frost Locker: New Research Reveals Mild Cold—Not Extreme Cold—Delivers Real Health Benefits of Cold Therapy
  • PatientNow Acquires Recura, the AI Growth Engine Powering Practice Growth
  • SprintRay Retainers Available in Allentown from Exeter Smiles
  • Genuine Smiles Unveils New User-Friendly Website
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us